MedTech Spectrum

Article Name Regulatory

Edwards Lifesciences announced it has entered into an agreement to acquire JenaValve

Peijia to maintain exclusive rights in Greater China to commercialize JenaValve's Trilogy Transcatheter Heart Valve (THV) System

25th July, 2024

AtriCure receives regulatory approval to sell AtriClip devices in China

AtriCure also plans to partner with leading medical institutions in China

23rd July, 2024

AiMeD hails Union Budget-2024; will give a boost to overall economic growth: Rajiv Nath

Medical devices industry was expecting more for quality and affordable healthcare: AiMeD Forum Coordinator Rajiv Nath

23rd July, 2024

MediTech Stackathon 2024 to Drive Explosive Growth

India's MedTech industry holds immense potential, with projections estimating a growth rate of 28 per cent annually, and hitting $50 billion by 2030. India is the fourth largest market for medical devices in Asia and among the top 20 globally. Net imports for 2022-23 stands at $4.101 billion with an import coverage ratio of 0.45. The sector has witnessed a surge in imports, driven primarily by countries like the US, China, and Germany, however, India's robust policy ecosystem presents opportunities for exports and reducing import dependence through domestic manufacturing. Exports have overtaken imports in consumables and disposables during the last year. The industry now needs to continue with the momentum in other pillars of the medtech sector. Against this promising backdrop, the Department of Pharmaceuticals rolled out MediTech Stackathon 2024, in a bid to harness the collective expertise of stakeholders to ultimately propel the industry towards unparalleled heights of innovation and self-reliance. Let’s explore how the Indian medtech industry is prepping for the big leap.

01st July, 2024

InnoVoyce Secures FDA Clearance for VYLO™ Laser System

Innovative 455nm blue light laser offers unparalleled precision and versatility for a wide range of surgical procedures, marking a significant milestone in medical technology.

31st May, 2024

Thermo Fisher Gains EU IVDR Compliance for CytoScan Dx Assay and ChAS Dx Software

New compliance ensures enhanced safety and efficacy for cytogenetic testing in the EU, advancing diagnostic capabilities.

31st May, 2024

IOTA Diagnostic receives CDSCO approval for cervical cancer screening test

M-Strip is an indigenously built novel advancement for cervical cancer screening

28th May, 2024

WHO approves largest number of regulatory agencies for medical products

Decision is based on the recommendation by the WHO technical advisory group

22nd May, 2024

UK Govt unveils AI Airlock to address challenges for regulating medical devices using AI

AI Airlock can enhance the relationship between developers and manufacturers

21st May, 2024

Exploring Japan's Healthcare Landscape, Opportunities, and Challenges at MEDICAL JAPAN TOKYO

Tokyo, Japan - Connecting Healthcare Innovators: Exploring New Opportunities at the Premier Medical Trade Show by RX Japan Ltd.

20th May, 2024

Government of India launches Meditech Stackathon 2024

Industry captains and key stakeholders to brainstorm on the Value Chain Mapping of the select medical devices

07th May, 2024

Secretary DoP expounds concept of ‘Proximate Advantage’ at MTaI fraternity meeting in India

First of its kind, think tank event coming up for the MediTech sector called the ‘India MediStack’

08th April, 2024

Johnson & Johnson Innovation names finalists in atopic advancements QuickPitch

Johnson & Johnson QuickPitch finalists revealed in atopic advancements

13th March, 2024

Zidebactam/Cefepime (ZaynichTM) successful in renal transplant patient with extreme-drug resistant Pseudomonas infection

Promising treatment for extreme-drug resistant Pseudomonas infection in renal transplant patients"

12th March, 2024

A Global Milestone in Innovative Pancreatic Cancer Therapy

Suppression of pancreatic cancer and increased survival rates in animals implanted with human pancreatic cancer cells when treated with biologic agent BGX, a proprietary targeted therapy developed in-house by BioGate

07th March, 2024